TREML2 Protein (TREM-like transcript 2)

TREML2 Protein (TREM-like transcript 2)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TREML2 Protein (TREM-like transcript 2)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>TREML2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>TREML2 (TREM-like transcript 2)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=TREML2" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

TREML2 (TREM-like transcript 2) is a member of the triggering receptor expressed on myeloid cells (TREM) family of proteins. It is a single-pass type I membrane protein with an Ig-like V-type domain that plays important roles in immune cell function, particularly in myeloid cells including [microglia](/cell-types/microglia), macrophages, and dendritic cells [1][2]. TREML2 has emerged as a significant protein in neurodegenerative disease research due to its genetic association with [Alzheimer's disease](/diseases/alzheimers-disease) risk and its role in microglial phagocytosis and neuroinflammation [3][4].

TREML2 Protein (TREM-like transcript 2)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TREML2 Protein (TREM-like transcript 2)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>TREML2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>TREML2 (TREM-like transcript 2)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=TREML2" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

TREML2 (TREM-like transcript 2) is a member of the triggering receptor expressed on myeloid cells (TREM) family of proteins. It is a single-pass type I membrane protein with an Ig-like V-type domain that plays important roles in immune cell function, particularly in myeloid cells including [microglia](/cell-types/microglia), macrophages, and dendritic cells [1][2]. TREML2 has emerged as a significant protein in neurodegenerative disease research due to its genetic association with [Alzheimer's disease](/diseases/alzheimers-disease) risk and its role in microglial phagocytosis and neuroinflammation [3][4].

The TREM family includes several related proteins: TREM1, TREM2, TREML1, TREML2, TREML3, and TREML4. While TREM2 has received extensive attention in AD research following the discovery of disease-associated variants, TREML2 shares structural similarity and has complementary or distinct functions in immune regulation [5][6]. TREML2 is expressed primarily in myeloid cells and is particularly important in the central nervous system where it modulates microglial function.

Structure and Biochemistry

Protein Architecture

TREML2 is a type I transmembrane protein with the following structural features [7][8]:

• Extracellular Ig-like domain: The N-terminal portion contains an immunoglobulin V-type (IgV) domain that mediates ligand binding. This domain shares approximately 40% sequence similarity with TREM2's IgV domain.
• Transmembrane domain: A short hydrophobic transmembrane helix anchors the protein in the cell membrane
• Cytoplasmic tail: Contains a short cytoplasmic domain with potential signaling motifs

Relationship to TREM2

TREML2 shares significant structural and functional homology with TREM2:

• Both proteins have similar Ig-like extracellular domains
• Both signal through the same adaptor protein DAP12 (TYROBP)
• However, TREML2 has distinct ligand specificity and expression patterns
• TREML2 may act as a functional paralog or decoy receptor for TREM2 ligands

Ligand Interactions

TREML2 binds to various ligands including [9][10]:

• Lipids: Various lipid species including phosphatidylserine and oxidized lipids
• Apolipoproteins: ApoE and other apolipoproteins
• Bacterial products: Certain bacterial cell wall components
• TREM2 ligands: May compete with or complement TREM2 ligand binding

Normal Physiological Function

Immune Cell Regulation

TREML2 plays multiple roles in immune cell function [11][12]:

Inflammatory Response Modulation

• TREML2 regulates cytokine production by macrophages and dendritic cells
• Can both enhance and suppress inflammatory responses depending on context
• Modulates the balance between pro-inflammatory and anti-inflammatory states

Phagocytosis

• TREML2 participates in cellular debris clearance
• Involved in phagocytosis of apoptotic cells and pathogens
• Complements TREM2-mediated phagocytosis in myeloid cells

Immune Cell Activation

• Acts as a co-stimulatory molecule for T-cell activation
• Modulates dendritic cell maturation and antigen presentation
• Regulates platelet activation and function

Central Nervous System Function

In the brain, TREML2 is expressed by microglia and modulates [13][14]:

Microglial Phagocytosis

• TREML2 contributes to amyloid-beta clearance
• Regulates microglial uptake of cellular debris
• Modifies the microglial inflammatory response to pathological stimuli

Neuroinflammation

• TREML2 signaling influences cytokine production by microglia
• Can modulate the neurotoxic vs. protective microglial phenotype
• May be involved in the transition from acute to chronic neuroinflammation

Role in Neurodegenerative Diseases

Alzheimer's Disease

TREML2 is genetically and functionally associated with AD risk [15][16][17]:

Genetic Association

• TREML2 variants influence AD risk, though with smaller effect size than TREM2
• Certain TREML2 polymorphisms are associated with increased disease risk
• The genetic effect may be independent of or interact with TREM2 variants

Microglial Function

• TREML2 modulates microglial activation and phagocytosis
• Influences amyloid clearance efficiency
• Regulates neuroinflammation in the AD brain

Therapeutic Implications

• TREML2 agonists may enhance beneficial microglial responses
• Targeting TREML2 could complement TREM2-based therapies
• May provide an alternative approach for AD immunotherapy

Parkinson's Disease

TREML2 may play a role in PD pathogenesis [18]:

• Altered TREML2 expression in PD brain tissue
• Potential involvement in alpha-synuclein clearance
• May modulate microglial responses to dopaminergic neuron injury

Stroke and Ischemia

TREML2 has protective roles in ischemic injury [19]:

• Modulates inflammatory responses following stroke
• Promotes phagocytosis of necrotic debris
• May influence recovery through immune modulation

Inflammatory and Autoimmune Diseases

TREML2 dysregulation contributes to various inflammatory conditions [20]:

• Altered expression in autoimmune diseases
• Modulates inflammatory responses in chronic inflammatory conditions
• Potential therapeutic target for immune-mediated diseases

Therapeutic Targeting

TREM2/TREML2 Agonists

Several therapeutic approaches are being developed [21][22]:

• Agonistic antibodies: Antibodies that activate TREM2/TREML2 signaling to enhance microglial function
• Small molecule agonists: Compounds that stimulate TREM2/TREML2 signaling pathways
• Protein replacement: Administration of soluble TREML2 or TREM2 ectodomains

Modulation Strategies

Therapeutic modulation approaches include:

• Enhancing phagocytosis: Agonists to boost debris and amyloid clearance
• Shifting microglial phenotype: Modulators to promote neuroprotective microglial states
• Reducing neuroinflammation: Anti-inflammatory approaches via TREML2 modulation

Biomarker Potential

TREML2 may serve as a biomarker:

• Soluble TREML2 (sTREML2) can be detected in cerebrospinal fluid
• Levels may correlate with disease stage or progression
• May help predict treatment response

Cross-Links

• [TREM2](/proteins/trem2) — Related protein in TREM family, major AD risk factor
• [TREML2 Gene](/genes/treml2) — Gene encoding TREML2 protein
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Primary disease association
• [Parkinson's Disease](/diseases/parkinsons-disease) — Secondary disease association
• [Microglia](/cell-types/microglia) — Primary cell type expressing TREML2
• [Microglial phagocytosis](/mechanisms/microglial-phagocytosis) — Key function modulated by TREML2
• [Neuroinflammation](/mechanisms/neuroinflammation) — TREML2 modulates inflammatory responses
• [Amyloid-beta clearance](/mechanisms/amyloid-beta-clearance) — TREML2 role in amyloid clearance
• [TREM2 signaling pathway](/mechanisms/trem2-signaling) — Related signaling mechanism

References

See Also

• [TREML2 Gene](/genes/treml2)
• [TREM2 Protein](/proteins/trem2)
• [TREM2 Signaling Pathway](/mechanisms/trem2-signaling)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Microglial Activation](/mechanisms/microglial-activation)
• [Microglial Phagocytosis](/mechanisms/microglial-phagocytosis)
• [Neuroinflammation](/mechanisms/neuroinflammation)